| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $2.81 (Beat by $0.06) |
| EPS GAAP Actual | $2.81 (Beat by $0.06) |
| Revenue Actual | $1.42281B |
| Revenue Surprise | Beat by $1422.81M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.77576 |
| EPS GAAP Estimate | $2.77576 |
| Revenue Estimate | $1.409473778B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 15.5 | 17.49 | 15.11386 | 15.90583 | 5 |
| Jun 2029 | 12.73 | 21.29 | 12.33767 | 13.26102 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -2.38 | -5.10229 | 1.42281B | 9.89% | 27.29M |
| FQ3 2025 (Sep 2025) | 2.38 | 2.38 | 1.33558B | 8.32% | 1335.58M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 1.34799B | 9.26% | 1347.99M |
| FQ1 2025 (Mar 2025) | 2.49 | 2.49 | 1.29174B | 7.34% | 1291.74M |
| FQ4 2024 (Dec 2024) | 2.43 | 2.43 | 1.28209B | 9.3% | 1282.09M |
| FQ3 2024 (Sep 2024) | 2.119 | 2.119 | 1.22451B | 21.35% | 1224.51M |
| FQ2 2024 (Jun 2024) | 1.989 | 1.989 | 1.2232B | 8.27% | 1223.2M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 1.19698B | 6.69% | 1196.98M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
2.77576
Consensus Revenue Estimates
1.409473778B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 3.13224 | -- | 3.07457 | 3.21803 | 3 |
| FQ1 2027 (Mar 2027) | 3.02646 | -- | 2.97074 | 3.10936 | 7 |
| FQ4 2026 (Dec 2026) | 2.97576 | 179.98 | 2.92098 | 3.05727 | 6 |
| FQ3 2026 (Jul 2026) | 2.45835 | 3.19 | 2.40381 | 2.52237 | 1 |
| FQ2 2026 (Jun 2026) | 2.87675 | -- | 2.82379 | 2.95554 | 3 |
| FQ1 2026 (Mar 2026) | 2.77576 | 10.29 | 2.70459 | 2.8266 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 1.55B | -- | 1.53B | 1.59B | 6 |
| FQ1 2027 (Mar 2027) | 1.5B | -- | 1.48B | 1.53B | 5 |
| FQ4 2026 (Dec 2026) | 1.49B | 4.72 | 1.47B | 1.52B | 5 |
| FQ3 2026 (Jul 2026) | 1.39B | 3.72 | 1.36B | 1.41B | 2 |
| FQ2 2026 (Jun 2026) | 1.46B | 7.49 | 1.44B | 1.49B | 5 |
| FQ1 2026 (Mar 2026) | 1.41B | 8.35 | 1.4B | 1.44B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.72229 | -2.38 | -5.10229 | 214.38% |
| FQ3 2025 (Sep 2025) | 2.38 | 2.38 | 100% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | 2.49 | 2.49 | 100% | |
| FQ4 2024 (Dec 2024) | 2.43 | 2.43 | 100% | |
| FQ3 2024 (Sep 2024) | 2.119 | 2.119 | 100% | |
| FQ2 2024 (Jun 2024) | 1.989 | 1.989 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $1.4B | $1.42B | $27.29M | 1.92% |
| FQ3 2025 (Sep 2025) | $0B | $1.34B | $1335.58M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.35B | $1347.99M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.29B | $1291.74M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.28B | $1282.09M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.22B | $1224.51M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.22B | $1223.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.2B | $1196.98M | 100% |